Physician profile
Melissa Tang
NPI 1598054942
$755.12
in general payments reported to CMS, 2019-2025
9 companies · $465 in 2025
The $465 reported for 2025 was more than what 92% of Emergency Medicine providers received nationally (typical 2025 total: $57.10).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $196 · 2023: $46.91 · 2024: $47.06 · 2025: $465.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $559.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $558.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $147.29 | 2025 | Avvigo Guidance System |
| Abbott Laboratories | $145.67 | 2025 | Eterna |
| Janssen Pharmaceuticals, INC | $126.50 | 2019-2024 | Xarelto |
| Chiesi USA, INC. | $123.14 | 2025 | Cleviprex |
| Novartis Pharmaceuticals Corporation | $101.12 | 2019 | |
| Abbvie INC. | $66.38 | 2023-2025 | Dalvance |
| Astrazeneca Pharmaceuticals LP | $16.08 | 2023 | Andexxa |
| Vertex Pharmaceuticals Incorporated | $14.52 | 2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $14.42 | 2024 | Jardiance |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Melissa Tang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.